Troy Carter, Sr.

Louisiana LA-02

Connect with this lawmaker

(202) 225-6636

100

2023 Score

Voting Record

Positively impacts reproductive freedom
Negatively impacts reproductive freedom

Year	Key Vote	How They Voted yea Vote for/in favor of nay Vote against — Abstained, absent, ineligible, present, resigned or deceased L Leader switched vote to preserve right to file a motion to reconsider S The speaker exercised their discretion not to vote
2023	Penalizing FDA for Expanding Mifepristone Access 7 Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024, H.R.4368. Good (R-VA) amendment to reduce to $1 the salary of the Director of the Office of Regulatory Policy at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.	nay
2023	Penalizing FDA for Expanding Mifepristone Access 6 Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024, H.R.4368. Good (R-VA) amendment to reduce to $1 the salary of the Director of the Office of Medical Policy at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.	nay
2023	Penalizing FDA for Expanding Mifepristone Access 5 Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024. Good (R-VA) amendment to reduce to $1 the salary of the Director of the Office of Compliance at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.	nay
2023	Prohibiting Funding for the White House Gender Policy Council Financial Services and General Government Appropriations Act, 2024, H.R.4664. Harshbarger (R-TN) amendment to eliminate funding for the White House Gender Policy Council which is charged with advancing gender equity and equality, including reproductive freedom. A vote for reproductive freedom was against the amendment.	nay
2023	Penalizing FDA for Expanding Mifepristone Access 4 Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024. Good (R-VA) amendment to reduce to $1 the salary of the Director of New Drugs at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.	nay
2023	Penalizing FDA for Expanding Mifepristone Access 3 Penalizing FDA for Expanding Mifepristone Access. Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024. Good (R-VA) amendment to reduce to $1 the salary of the Director of the Division of Risk Management at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.	nay
2023	Penalizing FDA for Expanding Mifepristone Access 2 Penalizing FDA for Expanding Mifepristone Access. Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024. Good (R-VA) amendment to reduce to $1 the salary of the Director of the Office of Surveillance and Epidemiology at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.	nay
2023	Penalizing FDA for Expanding Mifepristone Access 1 Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024. Good (R-VA) amendment to reduce to $1 the salary of the Director of the Center for Drug Evaluation and Research at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.	nay
2023	Prohibiting Funding for the Office of Population Affairs Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2024. Miller (R-IL) amendment to eliminate funding for the Office of Population Affairs which administers critical reproductive health programs. A vote for reproductive freedom was against the amendment.	nay
2023	Resolution on Fake Health Centers A resolution condemning violence against anti-abortion fake health centers and failing to recognize the real threats and attacks against reproductive health care providers and clinics, H.Con.Res.3.	nay
2023	Attack on Servicemembers’ Access to Abortion: Jackson Amendment National Defense Authorization Act for Fiscal Year 2024, H.R.2670. Jackson (R-TX) amendment to repeal the Department of Defense leave and travel policy that eases the burden of the statutory restrictions that force servicemembers and dependents to travel to access reproductive health care, including abortion services. A vote for reproductive freedom was against the amendment.	nay
2023	Attack on Servicemembers’ Access to Abortion: Final Passage National Defense Authorization Act for Fiscal Year 2024. Final Passage. A bill to authorize funding for certain defense, military, and national security programs which repeals the Department of Defense leave and travel policy that eases the burden of the statutory restrictions that force servicemembers and dependents to travel to access reproductive health care, including abortion services. (Some lawmakers who oppose reproductive freedom cast what appear to be votes in support of reproductive freedom; most observers recognize that those votes were cast for reasons unrelated to reproductive health.) A vote for reproductive freedom was against the bill.	nay
2023	Interference in Abortion Practice Born-Alive Abortion Survivors Protection Act, H.R.26. Wagner (R-MO) bill to interfere with the medical practice of abortion care under the threat of severe penalties.	nay
2022	Right to Contraception Act Final passage. A bill to protect both an individual’s right to use contraception and a health care provider’s right to provide contraceptives and related counseling. A pro-choice vote was in favor of the bill.	yea
2022	Ensuring Women’s Right to Reproductive Freedom Act Ensuring Women’s Right to Reproductive Freedom Act, H.R.8297. Final Passage. A bill to protect the rights of people who are blocked from accessing care in their state to travel to seek abortion care. A pro-choice vote was in favor of the bill.	yea
2022	Women’s Health Protection Act: Motion to End Debate Women’s Health Protection Act, H.R.8296. A bill to protect the federal right to abortion and block the barrage of state bans and restrictions on abortion intended to impede or outright deny access. A pro-choice vote was in favor of the bill.	yea
2021	Veterans’ Access to Contraception Veterans’ Access to Contraception. Equal Access to Contraception for Veterans Act, H.R.239. Final Passage. A bill to eliminate cost-sharing for veterans who access contraception through the Department of Veterans Affairs.	yea
2021	Women’s Health Protection Act H.R.3755 Women’s Health Protection Act, H.R.3755. Final Passage. A bill to protect the federal right to abortion and block the barrage of state bans and restrictions on abortion intended to impede or outright deny access. A vote for reproductive freedom was in support of the bill.	yea
2021	Pregnant Workers Fairness Act A bill to eliminate pregnancy discrimination and promote health and economic security by requiring employers to provide reasonable accommodations to working people for limitations arising out of pregnancy, childbirth, and related medical conditions. Final Passage.	yea
2021	DC Statehood Final Passage. A bill to admit Washington, DC as the 51st state.	—
2021	Equality Under the Constitution A joint resolution to eliminate the deadline for ratification of the Equal Rights Amendment (ERA) to the U.S Constitution, H.J.Res.17. Final passage.	—

Voting Record

Penalizing FDA for Expanding Mifepristone Access 7

Penalizing FDA for Expanding Mifepristone Access 6

Penalizing FDA for Expanding Mifepristone Access 5

Prohibiting Funding for the White House Gender Policy Council

Penalizing FDA for Expanding Mifepristone Access 4

Penalizing FDA for Expanding Mifepristone Access 3

Penalizing FDA for Expanding Mifepristone Access 2

Penalizing FDA for Expanding Mifepristone Access 1

Prohibiting Funding for the Office of Population Affairs

Resolution on Fake Health Centers

Attack on Servicemembers’ Access to Abortion: Jackson Amendment

Attack on Servicemembers’ Access to Abortion: Final Passage

Interference in Abortion Practice

Right to Contraception Act

Ensuring Women’s Right to Reproductive Freedom Act

Women’s Health Protection Act: Motion to End Debate

Veterans’ Access to Contraception

Women’s Health Protection Act H.R.3755

Pregnant Workers Fairness Act

DC Statehood

Equality Under the Constitution